Literature DB >> 3336240

Eosinophilia associated with perimyositis and pneumonitis.

S Lakhanpal1, J Duffy, A G Engel.   

Abstract

We describe a patient who had severe myalgias, bronchial asthma, pulmonary infiltrates, and eosinophilia. The findings on physical examination and the erythrocyte sedimentation rate were normal; there was no elevation of the serum creatine kinase. Muscle biopsy demonstrated an inflammatory exudate that contained eosinophils, localized primarily to the perimysium. Pulmonary and muscle manifestations responded to corticosteroids. Systemic eosinophilic disease associated with perimyositis or myositis has not been reported previously. In addition, we review the spectrum of eosinophilic muscle diseases--eosinophilic perimyositis, eosinophilic polymyositis, and focal eosinophilic myositis.

Entities:  

Mesh:

Year:  1988        PMID: 3336240     DOI: 10.1016/s0025-6196(12)62663-9

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  6 in total

Review 1.  The idiopathic inflammatory myopathies and their treatment.

Authors:  J Walton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

2.  Eosinophilia, myopathy, and neuropathy in a patient with repeated use of L-tryptophan.

Authors:  J J Goronzy; C M Weyand
Journal:  Klin Wochenschr       Date:  1990-07-17

3.  L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.

Authors:  L J Crofford; J I Rader; M C Dalakas; R H Hill; S W Page; L L Needham; L S Brady; M P Heyes; R L Wilder; P W Gold
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Tryptophan-induced eosinophilia-myalgia syndrome.

Authors:  L A Criswell; K E Sack
Journal:  West J Med       Date:  1990-09

5.  Two cases of neurological manifestations in eosinophilia: variations of one disease?

Authors:  S Ostrowitzki; S Zierz
Journal:  Clin Investig       Date:  1994-12

6.  Analytical characterization of peptide contaminants of L-tryptophan.

Authors:  E R Barnhart; V L Maggio; L R Alexander; M C Reilly; L T Gelbaum; W E Turner; T K Hine; L L Needham
Journal:  Arch Environ Contam Toxicol       Date:  1996-01       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.